Page 2 - Roche Ltd News Today

JATT Acquisition (NYSE:JATT – Get Free Report) and Curis (NASDAQ:CRIS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings. Valuation & Earnings This table compares JATT Acquisition […]

Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The

Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The

Sepsis Diagnostics Market by Method (Conventional, Automated), by Product (Blood Culture Media, Instruments, Assay kits & Reagents, Software), by Technology, by Usability (Laboratory Testing, Point-of-care Testing), by Pathogen, by End-User, by Regio

The surge in the immunoassay market is mainly from the rising occurrence of persistent conditions like cancer and lifestyle-related ailments such as diabetes mellitus. Notably, the uptick in

The global pharmacovigilance market is projected to expand significantly, with its size expected to reach around USD 19 billion by 2032 from USD 7.8 billion in 2022, growing at a CAGR of 9.3% during the forecast period from 2022 to 2032. This growth is driven by several key factors, including the increasing incidenc...

The growing prevalence of thrombotic disorders and the rising focus on personalized medicine & precision healthcare are projected to drive the global D-dimer testing market's growth during the

Dublin, May 22, 2024 (GLOBE NEWSWIRE) -- The

Ad hoc announcement pursuant to Art. 53 LR Jean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of DirectorsMathieu Simon to...

Ad hoc announcement pursuant to Art. 53 LR Jean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of DirectorsMathieu Simon to stand for re-election to the Board - taking